Cutaneous B-cell lymphoma of nails, pinna and nose treated with chlorambucil

Australasian Journal of Dermatology

Volumn 45, Issue 2, 2004, Pages 110-113

  Stanway, Amy ^a   Rademaker, Marius ^a   Kennedy, Ian ^a   Newman, Paul ^a  

^a WAIKATO HOSPITAL   (New Zealand)

Author keywords

Drug therapy; Lymphoid tissue; Skin

Indexed keywords

CHLORAMBUCIL;

AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; CUTANEOUS B CELL LYMPHOMA; EDEMA; ERYTHEMA; EXTERNAL EAR; FEMALE; HUMAN; HUMAN TISSUE; MULTIPLE CANCER; NAIL; NAIL BED; NAIL DISEASE; NOSE TUMOR; ROSACEA; SKIN LYMPHOMA; SKIN NODULE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CHLORAMBUCIL; EAR NEOPLASMS; EAR, EXTERNAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; NAIL DISEASES; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; REMISSION INDUCTION; SKIN NEOPLASMS;

EID: 2342501403     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00057.x     Document Type: Article

References (9)

1. Pandolfino T, Siegel R, Kuzel T, Rosen S, Guitart J. Primary cutaneous B-cell lymphoma: Review and current concepts. J. Clin. Oncol. 2000; 18: 2152-68.
2. Mackie R. Cutaneous lymphomas and lymphocytic infiltrates. In: Champion RH, Burton JL, Burns AD, Breathnach SM (eds). Textbook of Dermatology, Vol. 3, 6th edn. Oxford: Blackwell Science, 1998; 2373-402.
3. Gianotti B, Santucci M. Skin-associated lymphoid tissue (SALT) -related B-cell lymphoma (primary cutaneous B-cell lymphoma): A concept and a clinicopathologic entity. Arch. Dermatol. 1993; 129: 353-5.
4. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: A unique type of low grade lymphoma. Cliniocopathologic and immunologic study of 83 cases. Cancer 1991; 67: 2311-26.
5. Yap LM, Blum R, Foley P, McCormack C, Turner H, Seymour J, Prince M. Clinical study of primary cutaneous B-cell lymphoma using both the European Orgnaization for Research and Treatment of Cancer and World Health Organization classifications. Australas. J. Dermatol. 2003; 44: 110-15.
6. Drummer R. Immunomodulators in the treatment of cutaneous lymphoma. Expert Opin. Biol. Ther. 2002; 2: 279-86.
7. Pettengell R, Linch D. Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma. Br. J. Haematol. 2003; 121: 44-8.
8. Plosker G, Figgitt D. Rituximab: A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003; 63: 803-43.
9. Kennedy G, Blum R, McCormack C, Prince M. Treatment of primary cutaneous follicular centre lymphoma with rituximab: A report of two cases. Australas. J. Dermatol. 2004; 45: 34-7.